News and Analysis
Innovation, Technology, and IP News
“Magic Words” Unnecessary in Identifying Field of Endeavor for Analogous Art
Written by: Raymond S. Lu & Daniel Kiang NETFLIX, INC. v. DivX, LLC Before Hughes, Stoll, and Stark. Appeal from the Patent Trial and Appeal Board. Summary...
Patexia Insight 186: PGR vs. IPR: Analyzing Patent Challenge Outcomes
In the dynamic realm of intellectual property, remaining at the forefront is absolutely essential. Tomorrow marks the release of a pivotal milestone – the seventh edition of our...
Shire v. Blackburn: Drawing the Line Between FDA Drug Labeling Regulations and State Law on Product Liability
Written by: Ari Feinstein & Jane Dai, Ph.D. On June 2, 2023, drug manufacturer Shire US Inc. and related entity Shire LLC (collectively, “Shire”) asked the...
In the ever-evolving landscape of patent law, the Court of Appeals for the Federal Circuit (CAFC) has played a pivotal role in shaping the ... Read More »
Written by: Paige L. Cappelli
On September 6, 2023, the U.S. Food & Drug Administration (FDA) released three draft... Read More »
Written by:Brianne M. Kingery & Daniel Kiang
APPLE INC. v. COREPHOTONICS, LTD.
Before Stoll, Linn, and Stark. Appeal from the... Read More »
Written by: Raymond S. Lu & Daniel Kiang
NETFLIX, INC. v. DivX, LLC
Before Hughes, Stoll, and Stark. Appeal from the ... Read More »
In the dynamic realm of intellectual property, remaining at the forefront is absolutely essential. Tomorrow marks the release of a pivotal... Read More »
Written by: Ari Feinstein & Jane Dai, Ph.D.
On June 2, 2023, drug manufacturer Shire US Inc. and related entity Shire LLC... Read More »
In the world of patent law, Post-Grant Review (PGR) and Inter Partes Review (IPR) are crucial mechanisms for challenging... Read More »
Written by: Eric Wittgrove
Medtronic Minimed, Inc. and Minimed Distribution Corp. (“Medtronic”) were sued in a class... Read More »
Written by: Nima Zargari, Ph.D.
On August 15, 2023, the Food and Drug Administration (FDA) issued its updated guidance on... Read More »
In a significant turn of events, Google has secured a major legal victory as a Delaware federal judge has ruled to nullify... Read More »
CASE OF THE WEEK
In re Cellect, LLC, Appeal Nos. 2022-1293, -1294, -1295, -1296 (Fed. Cir. Aug. 28, 2023)
In a significant... Read More »
Written by: Christopher L. Lewis
Recent reports, including one by PitchBook, indicate that both venture capitalist funding for... Read More »
CASE OF THE WEEK
Volvo Penta of the Americas, LLC v. Brunswick Corp., Appeal No. 2022-1765 (Fed. Cir. Aug. 24, 2023)
In its... Read More »
Written by: Nefi R. Oliva & Nathan D. Reeves
IN RE CELLECT, LLC
Before Lourie, Dyk, and Reyna. Appeal from the... Read More »
We are proud to announce that tomorrow marks the release of the fourth edition of our ANDA Litigation Intelligence Report. This year's report... Read More »
Written by: Alistair J. McIntyre & Brandon G. Smith
Volvo Penta of the Americas, LLC, v. Brunswick Corp.
Before Moore... Read More »
Written by: Kenneth McNeill & Daniel P. Hughes
INCEPT LLC v. PALETTE LIFE SCIENCES, INC.
Before Newman, Schall, and... Read More »
In the intricate world of pharmaceuticals, where innovation meets regulation, ANDA litigation stands as a pivotal battleground... Read More »
CASE OF THE WEEK
Incept LLC v. Palette Life Sciences, Inc., Appeal Nos. 2021-2063, -2065 (Fed. Cir. Aug. 16, 2023)
In the... Read More »
Written by: Kenneth O. Aruda, Ph.D.
Software is increasingly used as a medical device, transforming the healthcare industry with the... Read More »
